Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study

Overview of attention for article published in Clinical Ophthalmology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,506 followers.

Confira os resultados de curto prazo do tratamento com Brolucizumabe em pacientes com degeneração macular relacionada à idade: um estudo multicêntrico de evidências do mundo real na Índia. Leia mais aqui: https://t.co/tRhPq5U0R8

10 Aug 2023

Reply Repost Favourite

RT @ophthopedia: Ophthopedia Update: Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degener…

10 Aug 2023

Reply Repost Favourite

Ophthopedia Update: Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study #Ophthomology #Eye #Ophthotwitter https://t.co/FfGv39LKsp

10 Aug 2023

Reply Repost Favourite

Dove Medical Press

Article Metrics

Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study

About this Attention Score

Mentioned by

Readers on